Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829374 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
A Phase 3 study, sponsored by Medivation.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,003
- Enrollment target
NCT00829374: Completed Phase 3 study, sponsored by Medivation.
NCT00829374 is a Phase 3 study that has completed, run by Medivation. The registered enrollment target is 1,003 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00829374, a Phase 3 study, has completed, sponsored by Medivation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,003 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Dimebon is safe and effective in patients with mild to moderate Alzheimer's disease on Donepezil.
Interventions
- DRUG Placebo comparator
- DRUG Dimebon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,003 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
What the finished NCT00829374 record still lists
NCT00829374 is an interventional study that assigns participants to a tested intervention. Its 1,003 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo comparator is the first listed.
NCT00829374 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00829374 about?
NCT00829374 is a clinical study titled "Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil". The purpose of this study is to determine if Dimebon is safe and effective in patients with mild to moderate Alzheimer's disease on Donepezil.
What is the current status of trial NCT00829374?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,003 participants. The study started on 2009-03. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00829374?
The interventions under investigation include: Placebo comparator (DRUG), Dimebon (DRUG).
Who is sponsoring clinical trial NCT00829374?
This trial is sponsored by Medivation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00829374's enrollment target sits among peer trials
1,003 295th of 2000 higher than 1,706 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia